Articles by Disease (Rhabdomyosarcoma)

Imidazo[1,2-a]pyridines: Promising Drug Candidate for Antitumor Therapy

Journal: Current Topics in Medicinal Chemistry
Volume: 16
Page: 3590-3616
Author(s): Richa Goel, Vijay Luxami and Kamaldeep Paul

Study of Splicing Factor, Proline- and Glutamine-rich by Proteomic Techniques in Human Malignant and Nonmalignant Cell Lines

Journal: Protein & Peptide Letters
Volume: 23
Page: 958-966
Author(s): Natalya V. Pashintseva, Sergey S. Shishkin, Kseniya V. Lisitskaya, Leonid I. Kovalev, Marina A. Kovaleva, Lidia S. Eryomina, Inna A. Kamenikhina, Lyudmila A. Novikova and Elchin G. Sadykhov

Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy

Journal: Current Drug Targets
Volume: 17
Page: 1687-1703
Author(s): Mahdi Shabani and Mohammad Hojjat-Farsangi

PLK1 Inhibition: Prospective Role for the Treatment of Pediatric Tumors

Journal: Current Drug Targets
Volume: 17
Page: 1661-1672
Author(s): Julia Alejandra Pezuk, Elvis Terci Valera and María Sol Brassesco

The Evolution of Diagnosis and Management of Pediatric Biliary Tract Rhabdomyosarcoma

Journal: Current Pediatric Reviews
Volume: 12
Page: 190-198
Author(s): Alpin D. Malkan and Israel Fernandez-Pineda

Repositioning the Old Fungicide Ciclopirox for New Medical Uses

Journal: Current Pharmaceutical Design
Volume: 22
Page: 4443-4450
Author(s): Tao Shen and Shile Huang

1,3,4-Thiadiazole Based Anticancer Agents

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16
Page: 1301-1314
Author(s): Alireza Aliabadi

Inhibitors of Cancer Stem Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16
Page: 1230-1239
Author(s): María E. García-Rubiño, César Lozano-López and Joaquín M. Campos

Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16
Page: 1142-1154
Author(s): Federica Biello, Giovanni Burrafato, Erika Rijavec, Carlo Genova, Giulia Barletta, Anna Truini, Simona Coco, Maria Giovanna Dal Bello, Angela Alama, Francesco Boccardo and Francesco Grossi

Persistent GP130/STAT3 Signaling Contributes to the Resistance of Doxorubicin, Cisplatin, and MEK Inhibitor in Human Rhabdomyosarcoma Cells

Journal: Current Cancer Drug Targets
Volume: 16
Page: 631-638
Author(s): Xiaojuan Wu, Hui Xiao, Ruoning Wang, Lingling Liu, Chenglong Li and Jiayuh Lin